We discuss its importance to human development, genomic stability, gene expression, epigenetic modifying agents as well as briefly introduce the expansive field of cancer epigenetics.
As per Figure 4, reprogramming efficiency, colony formation, pluripotent-associatedprotein expression indicated that pre-treatment with epigenetic modifying agents of somatic cells is beneficial for hESC extract-mediated reprogramming.
By forming either heterodimers or homodimers in the presence of nicotinamide adenine dinucleotide, CtBP is able to interact with gene-specific transcriptional factors and recruit several known epigenetic modifying enzymes such as LSD1, HDACs, G9a and so on to the target genes.
In this context, the combination of epigenetic modifying agents, such as azacitidine, lenalidomide and histone deacetylase inhibitors, with novel cellular therapy to include prophylactic DLIs, natural killer cell infusions, and leukemia-specific T cells or leukemia vaccines provides an exciting new avenue of research that may lead to improved treatment of leukemia relapse after allogeneic SCT.
The aberrant epigenetic patterns can be corrected by treatments with "epigenetic modifiers" or "epigenetic modifying agents" [ 77] that are in clinical trials of various phases [ 76].
Although some may function as individual enzymes, most epigenetic modifying proteins work as members of higher order protein complexes which often contain several epigenetic modifying enzymes, collectively controlling multiple distinct epigenetic marks.
Epigenetic modifying enzymes have been proven to play significant roles in gene regulation and cancer pathogenesis.
To identify key epigenetic barriers to the reprogramming process, we conducted a comprehensive loss-of-function screen of epigenetic modifying factors and identified Bmi1 as a critical epigenetic inhibitor of reprogramming (Zhou et al., 2016).
Epigenetic modifying factors are fundamental regulators of chromatin structure and gene expression during development and differentiation through the induction of chemical modifications on histones, DNA or via remodeling of the chromatin structure.
Transcriptional deregulation plays a major role in acute myeloid leukemia, and therefore identification of epigenetic modifying enzymes essential for the maintenance of oncogenic transcription programs holds the key to better understanding of the biology and designing effective therapeutic strategies for the disease.
